Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

AquiNovo Raises US$1.5 Million from Neovia

AquiNovo
Posted on: 27 Nov 17

MISGAV, Israel, Nov. 27, 2017 /PRNewswire/ -- AquiNovo Ltd. ("AquiNovo"), a portfolio company of The Trendlines Group ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced that it signed an agreement with Neovia for an aggregate investment of US$1.5 million.

Aquaculture is a fast-growing market with increasing economic opportunities. Increase in the world's population, particularly in Africa, Asia, and Latin America, and rising standards of living is estimated to result in a 60% increase in world production of animal proteins by 2040. Aquaculture production, which currently represents 4% of world animal protein production (41 million tonnes), is expected to grow by 450% in the next two decades. Due to a high feed conversion rate, aquaculture is a very effective system for protein production, in particular in emerging markets with limited purchasing power.

The aquaculture industry today needs sustainable solutions that provide higher yields, with lower production costs and reduced exposure to risks associated with longer growth periods. Bearing this in mind, Neovia has defined "intensive aquaculture" as one of its five global priority innovation fields and has implemented a holistic approach in innovative solutions for aquaculture.

Similarly, AquiNovo's technology addresses this challenge by developing solutions to improve farmed fish development. The company offers a non-GMO, non-hormonal, easy-to-use solution to be incorporated into the fish feed, providing hatcheries and fish farms with shorter time to market and additional growth cycles within existing infrastructure. Founded in 2015, AquiNovo is based in Misgav, Israel.

AquiNovo's CEO, Dr. Nissim Chen, remarked, "We believe that AquiNovo's technology will make a real difference for fish farmers world-wide. The combination of fish yield enhancement, with reduced exposure to risks associated with longer growth periods, will significantly contribute to risk management and revenues for fish farmers. Neovia's investment affirms their confidence in the Company, its vision and its achievements to date. We're excited to work with Neovia on the development of innovative solutions for the aquaculture market."

Hubert de Roquefeuil, President of Neovia, added, "Intensive aquaculture ranks among our five major innovation fields and we are very interested in collaborating with a recognized partner such as AquiNovo. Our strong position in the international aquaculture market, especially in Tilapia, will deeply benefit from this differentiating and innovative technology."

Contact:
Nissim Chen, CEO
AquiNovo Ltd.
+972-54-24-87-223
nissim@aquinovo.com
www.aquinovo.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 27/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.